Sensei Biotherapeutics : Company Presentation April 2024 -Ap

Conditionally Active Antibodies for


Immuno-oncology


Corporate Deck | April 2024


Disclaimer


This...

Related Keywords

United Kingdom , Japan , Italy , France , China , Spain , Germany , John Celebi , Christopher Gerry , Sensei Bio , Stephanie Krebs , Ron Weitzman , Seasoned Leadership Team , National Cancer Institute , While The Company , Development Agreement , Sensei Biotherapeutics Inc , Conditionally Active Antibodies , Private Securities Litigation Reform Act , Annual Report , Periodic Reports , Medical Officer , Commercial Opportunity , Diagnosed Patients Annually , Neck Cancer , Tumor Targeting , Major Obstacle , H Sensitive Antibodies Selectively Bind , Low Ph Tumor , Broad Commercial , Cooperative Research , National Cancer , Checkpoint Extensively Expressed , Cancer Immunonol Res ,